• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

National Surveillance for Unknown Transfusion-Transmitted Infections

March 13, 2024

The prevention of transfusion-transmitted infections (TTI) is largely based on recruiting donors at low risk of being infected with a TTI and using screening assays to identify known pathogens. However, a small, ever-present risk of transfusion-transmission of unknown pathogens or those with long incubation times remains. To investigate the risk of unknown TTI, researchers in Sweden developed a two-pronged algorithm to search a nationwide Swedish transfusion database (SCANDAT-3S) for concordance for 1155 disease entities between donors and recipients using a series of retrospective cohort analyses.  From 1968-2017, 1.72 million patients (56% female; mean age of first transfusion, 65 years) received 18.97 million blood components (RBCs, plasma, platelet or whole blood units) from 1.04 million blood donors. Based on a median follow-up period of 4.5 years for recipients and 18.5 years for donors, researchers found evidence of 15 diseases caused by a TTI, 13 of which were validated by a second approach based on possible shared diseases among all recipients of a given donor.  While some of the transfusion-transmitted diseases found were expected such as HIV (before 1985) and viral hepatitis, others such as pneumonia, sepsis, gastroenteritis, and colitis of unknown origin require further investigation.  No strong evidence for any unknown TTI were found in Sweden, and this study serves as a proof-of-concept that nationwide databases can be used as a surveillance system for unknown TTI.

Reference:

Dahlen T, Jingchen Z, Busch MP, and G Edgren.  Using routine health-care data to search for unknown transfusion-transmitted disease:  a nationwide, agnostic retrospective cohort study.  The Lancet Digital Health 2024 (6); e105-3113. 

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Plasma Exchange Does Not Reduce Risk of Death for Patients with Severe ANCA-Associated Vasculitis

  • VIDEO: Transfusion Transmitted Babesiosis

  • Updated FDA Guidance for Blood Donor Eligibility for Blood Pressure and Pulse

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley